ACP
MED icon

Aviance Capital Partners’s Medifast MED Stock Holding History

Aviance Capital Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,676
Closed -$332K – 327
2024
Q1 		$332K Buy
8,676
+1,506
+21% +$72.9K 0.05% 246
2023
Q4 		$482K Buy
7,170
+139
+2% +$9.68K 0.1% 174
2023
Q3 		$526K Sell
7,031
-228
-3% -$20.2K 0.12% 165
2023
Q2 		$669K Buy
7,259
+4,188
+136% +$373K 0.14% 161
2023
Q1 		$318K Buy
3,071
+116
+4% +$12.9K 0.07% 213
2022
Q4 		$341K Buy
+2,955
New +$344K 0.08% 206

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Aviance Capital Partners's MED Position: Q2 2024 in Review

Aviance Capital Partners sold out of Medifast (MED) in Q2 2024, closing a stake of 8,676 shares — an estimated $332K sold.

Aviance Capital Partners first reported a position in MED in Q4 2022 and held it in 6 quarters. The position peaked at $669K in Q2 2023. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Aviance Capital Partners reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Aviance Capital Partners sold 8,676 Medifast shares in Q2 2024, an estimated $332K.
  • Aviance Capital Partners first reported a position in Medifast in Q4 2022 and held it in 6 quarters.
  • Aviance Capital Partners's Medifast position peaked at $669K in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Aviance Capital Partners's 13F filing for Q2 2024, filed 9 Aug 2024.